Frontiers in Pharmacology | Pharmacoepidemiology

Original Research

Published on 17 Dec 2024

Anti-migraine medications safety during pregnancy in the US

in Pharmacoepidemiology

A. Bérard
S. Strom
D. Albrecht
S. Kori

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1481378

874 views

Original Research

Published on 17 Dec 2024

A real-world pharmacovigilance study of Sorafenib based on the FDA Adverse Event Reporting System

in Pharmacoepidemiology

Dongdong Zhang
Ying Cai
Yixin Sun
Peiji Zeng
Wei Wang
Wenhui Wang
Xiaohua Jiang
Yifan Lian

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1442765

1,530 views

Original Research

Published on 16 Dec 2024

Use of non-specific immunoglobulins in Catalonia in three third-level hospitals: a descriptive analysis of a hospital-prescribed medication registry

in Pharmacoepidemiology

J. Riera-Arnau
E. Ballarín
R. Llop
E. Montané
P. Hereu
G. Vancells
N. Padullés-Zamora
A. M. Barriocanal
G. Cardona-Peitx
C. Casasnovas

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1420682

874 views

Original Research

Published on 16 Dec 2024

Cost-effectiveness analysis of combining lenalidomide with R-CHOP for treating diffuse large B-cell lymphoma in China

in Pharmacoepidemiology

Rongqi Li
Yuhan Zeng
Yizhang Chen
Zhongjiang Ye
Chuang Chen
Jianhui Yang
Jing Fu
Tao Zhou
Danna Jiang
Sunting Qin

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1412743

706 views

Original Research

Published on 13 Dec 2024

Drug-induced retinal vein occlusion: a disproportionality analysis from the FDA adverse event reporting system (2004–2023)

in Pharmacoepidemiology

Xiao-Dong Chen
Kun-Hong Xiao
Chao-Bing Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1480269

1,803 views
1 citation

Original Research

Published on 11 Dec 2024

A real-world pharmacovigilance study of neuroleptic malignant syndrome based on FDA adverse event reporting system

in Pharmacoepidemiology

Yu Zhang
Wei Deng
Minjian Wang
Siying Luo
Song Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1438661

1,239 views
1 citation

Original Research

Published on 11 Dec 2024

Ophthalmic corticosteroids-related adverse events: the FDA adverse event reporting system (FAERS) database pharmacovigilance study

in Pharmacoepidemiology

Chengzhi Liu
Xinyu Wang
Xusheng Cao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1502047

1,510 views

Original Research

Published on 11 Dec 2024

Use of fluoroquinolones and risk of rhegmatogenous retinal detachment: a retrospective cohort study using two nationwide representative claims databases

in Pharmacoepidemiology

Ting-Yu Lin
Jiun-Ling Wang
Grace Hsin-Min Wang
Yu-Yun Huang
Ming-Ching Chen
Yaa-Hui Dong
Wei-Hsuan Lo-Ciganic

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1414221

1,012 views

Original Research

Published on 05 Dec 2024

Spontaneous adverse drug reactions reported in a thirteen-year pharmacovigilance program in a tertiary university hospital

in Pharmacoepidemiology

E. Montané
Y. Sanz
S. Martin
C. Pérez-Mañá
E. Papaseit
O. Hladun
G. De la Rosa
M. Farré

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1427772

1,350 views

Original Research

Published on 03 Dec 2024

Global research trends in therapeutic drug monitoring of antimicrobials from 2000 to 2023: a bibliometric analysis

in Pharmacoepidemiology

Hao Li
Manxue Jiang
Lingti Kong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1474878

11,936 views

Original Research

Published on 02 Dec 2024

Cardiovascular toxicity risk assessment of tyrosine kinase inhibitors: a pharmacovigilance study using the VigiBase database

in Pharmacoepidemiology

Yusuke Igawa
Hirofumi Hamano
Satoru Esumi
Tatsuaki Takeda
Makoto Kajizono
Ryo Kikuoka
Ikuya Kimura
Yoshito Zamami

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1472008

1,869 views
1 citation

Original Research

Published on 29 Nov 2024

Interactions of warfarin with COVID-19 vaccine/drugs, monoclonal antibodies, and targeted anticancer agents from real-world data mining

in Pharmacoepidemiology

Yan Gao
Qingsong Huang
Jun Li
Junsheng He
Fang Qian
Juanjuan Yi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1418997

1,501 views
1 citation

Perspective

Published on 27 Nov 2024

The reporting of disproportionality analysis in pharmacovigilance: spotlight on the READUS-PV guideline

in Pharmacoepidemiology

Michele Fusaroli
Francesco Salvo
Charles Khouri
Emanuel Raschi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1488725

1,165 views
2 citations

Original Research

Published on 22 Nov 2024

Drug-induced hearing disorders: a disproportionality analysis of the FAERS database

in Pharmacoepidemiology

Baojian Li
Xiaoling Hu
Zichen Yue

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1480994

2,159 views
1 citation

Original Research

Published on 21 Nov 2024

Using machine learning to identify risk factors for pancreatic cancer: a retrospective cohort study of real-world data

in Pharmacoepidemiology

Na Su
Rui Tang
Yice Zhang
Jiaqi Ni
Yimei Huang
Chunqi Liu
Yuzhou Xiao
Baoting Zhu
Yinglan Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1510220

1,054 views
1 citation

Systematic Review

Published on 21 Nov 2024

Efficacy of combination therapy of vitamin D and bisphosphonates in the treatment of postmenopausal osteoporosis: a systematic review and meta-analysis

in Pharmacoepidemiology

Yuangui Yang
Mingyue Yang
Xuanyi Su
Feibin Xie

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1422062

1,894 views